OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Home » Week of 4/8/24-4/12/24
The Viridian Value Tracker is the most comprehensive valuation product in the industry.
We modified our sector valuation tables to more clearly show the revenue and EBITDA multiples for 2023, 2024, and 2025. The Cultivation and Retail sector now trades at a median of 6.39x 2024 EBITDA and 1.26x 2023 Revenue. Many analysts are now valuing companies based on 2025 multiples, which are now 6.27x EBITDA and 1.04x revenues.
We modified our sector valuation tables to more clearly show the revenue and EBITDA multiples for 2023, 2024, and 2025. The Cultivation and Retail sector now trades at a median of 6.39x 2024 EBITDA and 1.26x 2023 Revenue. Many analysts are now valuing companies based on 2025 multiples, which are now 6.27x EBITDA and 1.04x revenues.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.
Copyright Viridian Capital Advisors © 2022